Wedbush Downgrades Syros Pharmaceuticals (SYRS) to Neutral

January 17, 2020 6:57 AM EST
Get Alerts SYRS Hot Sheet
Price: $4.62 -2.53%

Rating Summary:
    8 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten downgraded Syros Pharmaceuticals (NASDAQ: SYRS) from Outperform to Neutral with a price target of $9.00.

For an analyst ratings summary and ratings history on Syros Pharmaceuticals click here. For more ratings news on Syros Pharmaceuticals click here.

Shares of Syros Pharmaceuticals closed at $9.20 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades